Lundbeck again.

Lundbeck’s research will in future concentrate on three main areas of biology: neurodegeneration, neuroinflammation and synaptic transmission. These areas are relevant to a wide range of brain disorders, including depression, schizophrenia, Parkinson’s, Alzheimer’s and Huntington’s diseases.

O.K. so the cynic inside me is worried about why Lundbeck  is concentrating on these particular diseases?

Is it because they will never have to answer to anyone as to the side effects of their medication?

Any adverse reaction with these poor unfortunate patients could just as easily be put down to the illness! (Just like they tried to do with Shane)

The article below serves as an example of Lundbecks questionable  practices…

Owen Dyer

May 10, 2003

The Danish drug company Lundbeck breached the UK industry code of practice in the way it advertised the successor to its top selling product, the antidepressant citalopram (Cipramil), the drug industry’s watchdog has ruled. The company claimed that its new offering, escitalopram (Cipralex), was more effective than citalopram, even though the two drugs have exactly the same active ingredient.
Escitalopram reached the market in June last year, just as citalopram’s British patent ran out and the first generic competitor went on sale in Germany. The new drug is identical to the old one, except that an inert isomer has been removed from the formulation. Critics contend that this practice is designed to win a new patent without the need to develop a genuinely new drug. Can they be trusted?????

One thought on “Lundbeck again.

  1. They just think they can do what they like, and the problem is that they do and get away with it. And then their cover up is that they put it down to the patient’s illness, as you said, with total disregard for the people they’ve effected with their greed. As long as they think they’ve covered up, they couldn’t care less. I wonder if these people sleep as well at night as the rest of us do after what they did to Shane.

    Like

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s